FindTrial
Sign In

Novel coronavirus pneumonia (COVID-19) and Symptomatic Venous Thromboembolism: a Multicenter Retrospective Study

Novel coronavirus pneumonia (COVID-19) and Symptomatic Venous Thromboembolism: a Multicenter Retrospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033055
Enrollment
Unknown
Registered
2020-05-19
Start date
2020-05-20
Completion date
Unknown
Last updated
2020-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

symptomatic VTE:Case group
non-VTE :Control group

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with COVID-19 diagnosed by nucleic acid test and subsequent symptomatic VTE in 16 centers (case group); and 1:2 matched patients who did not have a VTE event.

Exclusion criteria

Exclusion criteria: 1) Asymptomatic VTE, or VTE present prior to COVID-19; 2) The diagnosis of VTE was not based on imaging findings; 3) Three kinds of important data including D-dimer, fibrinogen, and acquired risk factors for VTE were absent.

Design outcomes

Primary

MeasureTime frame
Symptomatic venous thromboembolism;—

Secondary

MeasureTime frame
Death;—

Countries

China

Contacts

Public ContactYu Hu

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

dr_huyu@126.com+86 13986183871

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026